Nitya Wadhwa

CDSA

Dr. Wadhwa is trained as a paediatrician and after practicing for a few years, transitioned to become a physician-scientist. She has been doing clinical research for more than a decade and leads her research programme at THSTI. She has been associated with several large multi-centre clinical trials using zinc for treatment of various childhood illnesses, surveillance for H-influenzae B in tertiary hospitals, establishing a large cohort of pregnant women to find solutions for adverse pregnancy outcomes, and observational studies to understand the development and maturation of the neonatal immune system.

Her primary research interest is finding solutions for neonatal and early life morbidity and mortality. She is the PI for a large multi-country multi-centre clinical trial to measure the efficacy of adjunct zinc for the treatment of young infant sepsis and co-PI on another large multi-country multi-site clinical trial to test the efficacy of immediate continuous KMC in reducing neonatal mortality. Since 2017, she has been associated with CDSA as its faculty in-charge. She has extended her scientific training and analytical thinking to grow CDSA and establish it as an academic clinical research unit where the focus is on academia-led, multi-centre, clinical trials/studies on public health issues of national importance.